Hyundai BioLand Co Ltd
KOSDAQ:052260
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hyundai BioLand Co Ltd
KOSDAQ:052260
|
KR |
|
I
|
Imperium Financial Group Ltd
HKEX:8029
|
HK |
|
C
|
China Dasheng Biotechnology Co
OTC:CDBT
|
US |
|
M
|
Millennium Group Corporation Asia PCL
SET:MGC
|
TH |
|
Tobu Railway Co Ltd
TSE:9001
|
JP |
|
W
|
Woodside Petroleum Ltd
XBER:WOPA
|
AU |
|
Bank of Hawaii Corp
NYSE:BOH
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Hyundai BioLand Co Ltd's stock price target?
Not Available
Hyundai BioLand Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Hyundai BioLand Co Ltd's Revenue forecast?
Projected CAGR
30%
For the last 14 years the compound annual growth rate for Hyundai BioLand Co Ltd's revenue is 5%. The projected CAGR for the next 1 year is 30%.
What is Hyundai BioLand Co Ltd's Operating Income forecast?
Projected CAGR
81%
For the last 14 years the compound annual growth rate for Hyundai BioLand Co Ltd's operating income is -2%. The projected CAGR for the next 1 year is 81%.
What is Hyundai BioLand Co Ltd's Net Income forecast?
Projected CAGR
7 137%
For the last 14 years the compound annual growth rate for Hyundai BioLand Co Ltd's net income is -25%. The projected CAGR for the next 1 year is 7 137%.
